The Children’S Place, Inc.
$188.08M- Market cap
- $62.49M
- Debt
- +$131.08M
- Cash
- −$5.49M
Capital structure 32% equity / 68% debt · EV / Revenue 0.16x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PLCE stock price at discount vs ROIV $2.81 current versus $166.05K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ROIV's multiple
Implied fair value · at PLCE's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PLCE FY 2026 (ended Jan 31, 2026) · ROIV FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 32% equity / 68% debt · EV / Revenue 0.16x
Capital structure 98% equity / 2% debt · EV / Revenue 2584.97x
ROIV carries the larger enterprise value at $21.35B against $188.08M; PLCE trades on the lower EV / Revenue multiple (0.16x vs 2584.97x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
THE CHILDREN’S PLACE, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
ROIVANT SCIENCES LTD. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-2.42x
0.09x
Net debt / EBITDA
Leverage against operating earnings
-2.04x
24.52x
Cash and equivalents
Liquid reserves on the balance sheet
$5.49M
$4.29B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABERCROMBIE & FITCH CO /DE/
PLCE vs ANF
FOOT LOCKER, INC.
PLCE vs FL
WOLVERINE WORLD WIDE INC /DE/
PLCE vs WWW
GAP INC
PLCE vs GAP
Sally Beauty Holdings, Inc.
PLCE vs SBH
TILLY'S, INC.
PLCE vs TLYS
Revolution Medicines, Inc.
PLCE vs RVMD
INCYTE CORP
PLCE vs INCY
Sarepta Therapeutics, Inc.
PLCE vs SRPT
EXELIXIS, INC.
PLCE vs EXEL
VERTEX PHARMACEUTICALS INC / MA
PLCE vs VRTX
$131.08M
$412.94M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.